Asensus Surgical Inc (NYSE American:ASXC)

0.696
BATS BZX Real-Time Price
As of 12:40pm ET
 +0.016 / +2.35%
Today’s Change
0.35
Today|||52-Week Range
2.37
-37.30%
Year-to-Date
SECTOR
Commercial Services
INDUSTRY
Miscellaneous Commercial Services
MARKET CAP
$160.8M

Company Description

Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System features a machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world while staying true to the principles of value-based healthcare. The company was founded by William N. Starling on August 19, 1988 and is headquartered in Durham, NC.

Contact Information

Asensus Surgical, Inc.
1 TW Alexander Drive
Durham North Carolina 27703
P:(919) 765-8400
Investor Relations:
(443) 213-0501

Employees

Shareholders

Mutual fund holders8.17%
Other institutional7.41%
Individual stakeholders1.60%

Top Executives

Anthony FernandoPresident Chief Executive Officer & Director
Shameze RampertabChief Financial Officer & Executive Vice President
Cameron PedersenVice President-Global Research & Development
Mark KlausnerInvestor Relations Contact
Amanda OwensGlobal Head-People